Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002392252 | SCV002703656 | likely benign | Inborn genetic diseases | 2018-01-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV003095272 | SCV003289571 | likely benign | Pyridoxine-dependent epilepsy | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003095272 | SCV004050039 | likely benign | Pyridoxine-dependent epilepsy | 2023-04-11 | criteria provided, single submitter | clinical testing |